Skip to main content
. Author manuscript; available in PMC: 2012 Aug 2.
Published in final edited form as: J Am Coll Cardiol. 2011 Aug 2;58(6):618–626. doi: 10.1016/j.jacc.2011.03.042

Table 2.

Association between circulating NT-proBNP, testosterone and sex hormone-binding globulin

Men Women

Association with log NT-proBNP Beta* (SE) P value Beta* (SE) P value
Entire sample
Single variable
Log free testosterone −0.30 (0.11) 0.007 −0.54 (0.05) <0.0001
Log sex hormone-binding globulin 0.23 (0.03) <0.0001 0.23 (0.02) <0.0001

Entire sample
Multivariable
Log free testosterone −0.03 (0.11) 0.78 −0.47 (0.06) <0.0001
Log sex hormone-binding globulin 0.12 (0.03) <0.0001 0.25 (0.02) <0.0001

Non-diabetics only
Multivariable
Log free testosterone −0.05 (0.12) 0.65 −0.45 (0.06) <0.0001
Log sex hormone-binding globulin 0.13 (0.03) 0.0001 0.24 (0.02) <0.0001
*

Beta coefficients represent the mean change in log NT-proBNP per 1 SD difference in log free testosterone or log sex hormone-binding globulin; For single variable analyses, N=1880 in men (both models); 2144 in women (model containing log free testosterone); and 2147 in women (model containing log sex hormone-binding globulin).

Adjusted for age, body mass index, systolic blood pressure, diastolic blood pressure, serum creatinine, antihypertensive medications, diabetes mellitus, and smoking; N=1871 in men (both models); 2123 in women (model containing log free testosterone); and 2126 in women (model containing log sex hormone-binding globulin).

Adjusted for age, body mass index, systolic blood pressure, diastolic blood pressure, serum creatinine, antihypertensive medications, smoking and homeostatic model assessment of insulin resistance; N=1650 in men (both models); 1857 in women (model containing log free testosterone); and 1859 in women (model containing log sex hormone-binding globulin).

HHS Vulnerability Disclosure